Breaking News Instant updates and real-time market news.

RHI

Robert Half

$55.96

0.01 (0.02%)

16:40
10/23/19
10/23
16:40
10/23/19
16:40

Robert Half sees Q4 EPS 94c-$1.00, consensus $1.00

Sees Q4 revenue $1.5B-$1.565B, consensus $1.55B. Guidance taken from Q3 earnings call prepared remarks.

  • 23

    Oct

RHI Robert Half
$55.96

0.01 (0.02%)

01/23/19
NRCS
01/23/19
NO CHANGE
Target $45
NRCS
Sell
Robert Half price 'too high', Kelly Services 'attractive', says Northcoast
Northcoast analyst John Healy is keeping his Sell rating and $45 price target on Robert Half (RHI) as part of his broader research note on staffing companies, saying that while business activity in Q4 was in growth mode with a 5.2% reported rate of increase, he sees its stock price as too high. Healy adds that Robert Half's longer term competitive dynamics and margin profile are concerning. The analyst has a positive view on Kelly Services (KELYA) from a risk-reward perspective however, keeping his Buy rating and $31 price target on the shares, as he sees the stock price trading below its intrinsic value.
01/30/19
RHCO
01/30/19
NO CHANGE
Target $70
RHCO
Hold
Robert Half price target lowered to $70 from $76 at SunTrust
SunTrust analyst Tobey Sommer lowered his price target on Robert Half to $70 after its Q4 results, saying that while the company generated higher margins and matched strong consulting demand with higher staff count of its own, he remains concerned by the revenue impact from the slowing macro data in Europe. The analyst kept his Hold rating on Robert Half, even though he is "intrigued by the company's cross-selling consulting and staffing services as a significant potential long-term driver of growth." Sommer also raised his FY19 EPS outlook by 6c to $4.00, adding that the ROIC for Q4 was a standout and "reflects the long term organic growth story" at Robert Half.
04/16/19
RBCM
04/16/19
INITIATION
Target $71
RBCM
Sector Perform
Robert Half initiated with a Sector Perform at RBC Capital
RBC Capital analyst Seth Weber initiated Robert Half with a Sector Perform rating and a price target of $71. The analyst says that it is "hard to argue" with the company's "impressive return on invested capital" and "attractive position", but he also sees the stock becoming less attractive relative to "other staffers" after its strong last-twelve-months and year-to-date performance. Given his anticipated scenario of a slowing macro revenue trajectory, Weber sees Robert Half shares moving "closer to fair value".
04/25/19
BMOC
04/25/19
NO CHANGE
Target $62
BMOC
Market Perform
Robert Half price target lowered to $62 from $68 at BMO Capital
BMO Capital analyst Jeffrey Silber lowered his price target on Robert Half to $62 and kept his Market Perform rating after its Q1 earnings miss, driven by decelerating revenues. The analyst notes slowing growth in most of the company's major segments amid "tougher comps,European slowing growth and more selective US clients."

TODAY'S FREE FLY STORIES

EVR

Evercore Partners

$76.43

0.64 (0.84%)

07:34
11/20/19
11/20
07:34
11/20/19
07:34
Initiation
Evercore Partners initiated  »

Evercore Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VVUS

VIVUS

$2.84

0.09 (3.27%)

07:33
11/20/19
11/20
07:33
11/20/19
07:33
Hot Stocks
VIVUS announces results of clinical study of Qysmia in patients with BED, BN »

VIVUS announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WWD

Woodward

$115.83

2.19 (1.93%)

07:32
11/20/19
11/20
07:32
11/20/19
07:32
Downgrade
Woodward rating change  »

Woodward downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

HOLX

Hologic

$47.17

0.43 (0.92%)

07:32
11/20/19
11/20
07:32
11/20/19
07:32
Hot Stocks
Clayton, Dubilier & Rice to acquire Cynosure from Hologic »

Clayton, Dubilier &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DAVA

Endava

$44.07

-0.05 (-0.11%)

07:31
11/20/19
11/20
07:31
11/20/19
07:31
Recommendations
Endava analyst commentary  »

Endava price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 21

    Nov

  • 26

    Nov

MYOS

MYOS

$1.49

(0.00%)

07:31
11/20/19
11/20
07:31
11/20/19
07:31
Hot Stocks
MYOS' Fortetropin shows muscle increase in accepted clinical trial presentation »

MYOS RENS, owner of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XCUR

Exicure

$2.60

0.13 (5.26%)

07:31
11/20/19
11/20
07:31
11/20/19
07:31
Initiation
Exicure initiated  »

Guggenheim starts Exicure…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

I

Intelsat

$6.08

-1.9 (-23.81%)

07:30
11/20/19
11/20
07:30
11/20/19
07:30
Upgrade
Intelsat rating change  »

Intelsat upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

MOGA

Moog Inc

$0.00

(0.00%)

, MOG

Moog Inc

$0.00

(0.00%)

07:30
11/20/19
11/20
07:30
11/20/19
07:30
Hot Stocks
Moog awarded $400M F-35 actuation system contracts from Lockheed Martin »

Moog (MOG) announced that…

MOGA

Moog Inc

$0.00

(0.00%)

MOG

Moog Inc

$0.00

(0.00%)

MOG.A

Moog

$88.00

0.39 (0.45%)

MOG.B

Moog

$81.29

(0.00%)

LMT

Lockheed Martin

$390.66

-2.07 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PM

Philip Morris

$83.45

-1.32 (-1.56%)

, JWN

Nordstrom

$35.51

-2.37 (-6.26%)

07:30
11/20/19
11/20
07:30
11/20/19
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

PM

Philip Morris

$83.45

-1.32 (-1.56%)

JWN

Nordstrom

$35.51

-2.37 (-6.26%)

FNV

Franco-Nevada

$98.66

-0.36 (-0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 21

    Nov

  • 05

    Dec

ARAV

Aravive

$6.69

0.19 (2.92%)

07:29
11/20/19
11/20
07:29
11/20/19
07:29
Conference/Events
Aravive to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

NWBI

Northwest Bancshares

$16.76

(0.00%)

07:28
11/20/19
11/20
07:28
11/20/19
07:28
Initiation
Northwest Bancshares initiated  »

Northwest Bancshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROK

Rockwell Automation

$196.69

-0.95 (-0.48%)

, ANSS

Ansys

$242.54

3.87 (1.62%)

07:27
11/20/19
11/20
07:27
11/20/19
07:27
Hot Stocks
Rockwell Automation, Ansys announce strategic partnership »

Rockwell Automation (ROK)…

ROK

Rockwell Automation

$196.69

-0.95 (-0.48%)

ANSS

Ansys

$242.54

3.87 (1.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 02

    Dec

  • 11

    Dec

XNCR

Xencor

$37.65

1.36 (3.75%)

07:27
11/20/19
11/20
07:27
11/20/19
07:27
Initiation
Xencor initiated  »

Xencor assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDT

Medtronic

$111.10

-0.15 (-0.13%)

07:26
11/20/19
11/20
07:26
11/20/19
07:26
Recommendations
Medtronic analyst commentary  »

Medtronic price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYGN

Myriad Genetics

$25.12

0.39 (1.58%)

07:25
11/20/19
11/20
07:25
11/20/19
07:25
Hot Stocks
Myriad Genetics says ACR adds Vectra test to list of disease activity measures »

Myriad Genetics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

MOR

MorphoSys

$28.95

0.75 (2.66%)

07:25
11/20/19
11/20
07:25
11/20/19
07:25
Initiation
MorphoSys initiated  »

Guggenheim starts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

YMAB

Y-mAbs Therapeutics

$28.51

-0.03 (-0.11%)

07:25
11/20/19
11/20
07:25
11/20/19
07:25
Initiation
Y-mAbs Therapeutics initiated  »

Guggenheim starts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOCS

Focus Financial Partners

$26.76

0.5 (1.90%)

07:25
11/20/19
11/20
07:25
11/20/19
07:25
Conference/Events
Focus Financial Partners to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

ACIW

ACI Worldwide

$36.43

2.73 (8.10%)

07:24
11/20/19
11/20
07:24
11/20/19
07:24
Hot Stocks
ACI Worldwide sees FY20 adjusted EBITDA of $425M-$445M »

This range compares to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JWCAF

James E Wagner Cultivation

$0.00

(0.00%)

07:23
11/20/19
11/20
07:23
11/20/19
07:23
Hot Stocks
James E Wagner Cultivation signs sales agreement with Kindred Partners »

James E. Wagner…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRUS

Merus

$15.50

-0.18 (-1.15%)

07:23
11/20/19
11/20
07:23
11/20/19
07:23
Initiation
Merus initiated  »

Merus assumed with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZYME

Zymeworks

$38.20

0.91 (2.44%)

, BGNE

BeiGene

$204.06

7.8 (3.97%)

07:22
11/20/19
11/20
07:22
11/20/19
07:22
Initiation
Zymeworks, BeiGene initiated  »

Guggenheim starts…

ZYME

Zymeworks

$38.20

0.91 (2.44%)

BGNE

BeiGene

$204.06

7.8 (3.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 27

    Feb

DFIN

Donnelley Financial Solutions

$9.58

-0.01 (-0.10%)

07:22
11/20/19
11/20
07:22
11/20/19
07:22
Conference/Events
Donnelley Financial Solutions management to meet with B. Riley FBR »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

MGNX

MacroGenics

$8.65

0.2 (2.37%)

07:21
11/20/19
11/20
07:21
11/20/19
07:21
Initiation
MacroGenics initiated  »

MacroGenics assumed with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 09

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.